Stanelco PLC
28 April 2008
28th April 2008
Stanelco plc ('Stanelco' or the 'Company')
AGM Statement and Interim Management Statement
The Company's Annual General Meeting will take place at 10am today at the
offices of Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London
WC2A 1PB.
The following comments will be made regarding current trading, financial
performance and outlook for the financial year. This statement covers the period
1 January 2008 to the date of this announcement and constitutes Stanelco's first
Interim Management Statement as required by the UK Listing Authority's
Disclosure and Transparency Rules.
Current Trading
The 2008 financial year has started well and in line with the expectations
indicated in the 2007 Annual Report.
Current sales from Biotec are in line with Board expectations and the Stanelco
Bioplastics team have begun to achieve some encouraging sales traction in a
number of end-user areas.
The market remains fast-moving, driven as it is by both changing legislative and
consumer requirements. We are concentrating on adapting and enhancing the
functional and commercial attributes of bioplastic materials which will be
essential to commercial success.
Development trials at the bioplastic pilot unit, commissioned recently in the
Company's UK facility, have started and an expansive set of trials are underway.
This unit is now being strengthened with the recruitment of further scientific
staff.
Stanelco RF Applications is continuing to develop its product range and has a
strong enquiries book. Sales are in line with Board expectations and last year.
Financial Performance
At 31st March we had cash of £7.5m and continue to consider sensible investment
opportunities for these funds.
Outlook
We expect continued good progress in the Company's main businesses. This gives
the Board confidence in the outlook for further commercialisation and
development in 2008.
For further information please contact:
Financial Dynamics
Jonathon Brill/Caroline Stewart
Tel: +44 (0) 207 831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.